NZ223619A - Sustained release tablet containing cefaclor, a hydrophilic polymer and an acrylic polymer - Google Patents

Sustained release tablet containing cefaclor, a hydrophilic polymer and an acrylic polymer

Info

Publication number
NZ223619A
NZ223619A NZ223619A NZ22361988A NZ223619A NZ 223619 A NZ223619 A NZ 223619A NZ 223619 A NZ223619 A NZ 223619A NZ 22361988 A NZ22361988 A NZ 22361988A NZ 223619 A NZ223619 A NZ 223619A
Authority
NZ
New Zealand
Prior art keywords
sustained release
release tablet
tablet containing
polymer
acrylic polymer
Prior art date
Application number
NZ223619A
Other languages
English (en)
Inventor
Peter Lloyd Oren
Werner Max Karl Seidler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ223619A publication Critical patent/NZ223619A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NZ223619A 1987-02-27 1988-02-24 Sustained release tablet containing cefaclor, a hydrophilic polymer and an acrylic polymer NZ223619A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1991587A 1987-02-27 1987-02-27

Publications (1)

Publication Number Publication Date
NZ223619A true NZ223619A (en) 1990-10-26

Family

ID=21795732

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ223619A NZ223619A (en) 1987-02-27 1988-02-24 Sustained release tablet containing cefaclor, a hydrophilic polymer and an acrylic polymer

Country Status (26)

Country Link
EP (1) EP0280571B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH082793B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR960005140B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1023765C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR243376A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE92309T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU604849B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1316110C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1741A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE280571T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK175620B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EG (1) EG18523A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2044825T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR930300027T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK125793A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU202747B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE61419B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL85538A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LV (1) LV10184B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX10558A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ223619A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH24358A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT86831B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU1831337C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA18251A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA881301B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
DE69131688T2 (de) * 1990-05-04 2000-05-25 Perio Products Ltd., Hahotzvim System zur arzneistoffabgabe im colon
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
JP2864737B2 (ja) * 1993-10-22 1999-03-08 株式会社ツムラ 徐放性製剤用基剤並びに徐放性製剤及び該製剤の製造方法
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
CA2251623C (en) * 1996-05-13 2006-12-19 Novartis Consumer Health S.A. Buccal delivery system
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
WO1999044614A1 (en) * 1998-03-03 1999-09-10 Daewoong Pharmaceutical Co., Ltd. Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
ES2306646T3 (es) 1999-02-09 2008-11-16 Pfizer Products Inc. Composiciones de farmacos basicos con biodisponibilidad incrementada.
KR100647901B1 (ko) * 1999-07-09 2006-11-17 보령제약 주식회사 세파클러-함유 서방성 약제조성물 및 그의 제조방법
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
DE60034368T2 (de) 1999-12-28 2008-01-03 Kimberly-Clark Worldwide, Inc., Neenah Verwendungs-abhängiges indikatorsystem für absorbierende artikel
HK1049131A1 (zh) 1999-12-28 2003-05-02 Kimberly-Clark Worldwide, Inc. 硬質表面用受控釋放抗菌擦
CA2393528C (en) 1999-12-28 2009-12-01 Kimberly-Clark Worldwide, Inc. A wiper containing a controlled-release anti-microbial agent
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
EP1330250B1 (en) 2000-10-30 2004-05-12 Lupin Limited Rapidly disintegrating sustained release cefuroxime axetil composition
EP1589951B1 (en) * 2003-01-03 2017-08-09 Supernus Pharmaceuticals, Inc. Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
EP2026815B1 (en) 2006-04-26 2011-01-26 Supernus Pharmaceuticals, Inc. Controlled released preparations of oxcarbazepine having sigmoidal release profile
WO2008059792A1 (fr) * 2006-11-13 2008-05-22 Kyorin Pharmaceutical Co., Ltd. Procédé de production d'un comprimé à libération prolongée
WO2010110436A1 (ja) 2009-03-27 2010-09-30 杏林製薬株式会社 塩基性添加剤を含有するマトリックス型徐放性製剤
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
KR20170015315A (ko) * 2014-06-10 2017-02-08 라이온 가부시키가이샤 청주 효모를 함유하는 정제
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151913B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1980-01-11 1983-09-03 Boots Co Ltd
JPS6024765B2 (ja) * 1981-11-27 1985-06-14 辰巳化学株式会社 セフアレキシンの持続性製剤の製造方法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法

Also Published As

Publication number Publication date
IL85538A0 (en) 1988-08-31
IE880545L (en) 1988-08-27
HUT46531A (en) 1988-11-28
KR960005140B1 (ko) 1996-04-22
IL85538A (en) 1991-09-16
AU1219388A (en) 1988-09-01
KR880009639A (ko) 1988-10-04
JPS63227519A (ja) 1988-09-21
UA18251A (uk) 1997-12-25
PH24358A (en) 1990-06-13
EP0280571B1 (en) 1993-08-04
AR243376A1 (es) 1993-08-31
EG18523A (en) 1993-04-30
AU604849B2 (en) 1991-01-03
EP0280571A3 (en) 1989-01-04
PT86831A (pt) 1988-03-01
PT86831B (pt) 1992-05-29
MX10558A (es) 1993-11-01
ES2044825T1 (es) 1994-01-16
DK175620B1 (da) 2004-12-27
EP0280571A2 (en) 1988-08-31
CN88101062A (zh) 1988-09-07
JPH082793B2 (ja) 1996-01-17
CN1023765C (zh) 1994-02-16
ES2044825T3 (es) 1994-11-16
DK98088D0 (da) 1988-02-25
ATE92309T1 (de) 1993-08-15
HK125793A (en) 1993-11-19
CA1316110C (en) 1993-04-13
HU202747B (en) 1991-04-29
DE3882739D1 (de) 1993-09-16
LV10184B (en) 1995-04-20
ZA881301B (en) 1989-10-25
DE280571T1 (de) 1993-08-12
DE3882739T2 (de) 1994-02-17
DK98088A (da) 1988-08-28
GR930300027T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-05-24
CY1741A (en) 1995-02-17
RU1831337C (ru) 1993-07-30
IE61419B1 (en) 1994-11-02
LV10184A (lv) 1994-10-20

Similar Documents

Publication Publication Date Title
NZ223619A (en) Sustained release tablet containing cefaclor, a hydrophilic polymer and an acrylic polymer
GB8910706D0 (en) Drug absorbates
EP0413281A3 (en) Drug carrier
NZ219140A (en) Sustained release capsule containing active adsorbed on polymer
ZA902096B (en) Intraoral medication releasing system
EP0297625A3 (en) Pressure-sensitive tablet
ZA874899B (en) Controlled release dosage form comprising acetaminophen,pseudeophedrine and dexbrompheniramine
AU3377789A (en) Acrylic polymers
AU1008288A (en) Catheter retaining device
EP0347748A3 (en) Pharmaceutical granules and tablets made therefrom
GB8821058D0 (en) Dispersion polymer polyols
JPS6429420A (en) Norbornenedicarboxyimide polymer
GB2208029B (en) Recordable data device and a data processing system using the same
JPS6431831A (en) Polyquinoxaline polymer and article containing the same
GB2201155B (en) Polymer materials
GB8919121D0 (en) Sustained release device
EP0294237A3 (en) Novel peroxide monomer and a polymer therefrom
GB2209319B (en) Handling device
GB8716995D0 (en) Polymer solutions
IE871898L (en) Controlled release drug containing fibres.
GB8816351D0 (en) Sustained drug release system
GB8816352D0 (en) Sustained drug release system
BG44130A1 (en) Polymer electroinsulation
BG46965A1 (en) Cold- pouring polymer hydroisolation
IE872675L (en) Sustained release pharmaceutical